A consortium announces the launch of a $57 million project to test inhaled and nasal vaccines with a goal of stopping infection from SARS-CoV-2 and other coronaviruses.
Quick takes: Next-gen coronavirus vaccines, H9N2 avian flu case in China, fatal plague in New Mexico
Published in COVID-19
More from COVID-19More posts in COVID-19 »
- Very few US adults getting new flu, COVID, RSV vaccines, even in nursing homes
- US respiratory virus activity remains low ahead of holiday season
- Antiviral COVID-19 drug molnupiravir tied to large drop in deaths in older patients
- Adults with migraines at higher risk of depression during pandemic, study shows